Related Content
Search Google Scholar for:
|
|
Science 21 October 1988: Vol. 242. no. 4877, pp. 426 - 430 DOI: 10.1126/science.3262925
|
|
Articles
Science, Vol 242, Issue 4877, 426-430
Copyright © 1988 by American Association for the Advancement of Science
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells
S Nakamura,
SZ Salahuddin,
P Biberfeld,
B Ensoli,
PD Markham,
F Wong-Staal,
and
RC Gallo
Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20892.
Studies of the biology and pathogenesis of Kaposi's sarcoma (KS) have been hampered by the inability to maintain long-term cultures of KS cells in vitro. In this study AIDS-KS-derived cells with characteristic spindle-like morphology were cultured with a growth factor (or factors) released by CD4+ T lymphocytes infected with human T-lymphotropic virus type I or II (HTLV-I or HTLV-II) or with human immunodeficiency virus type 1 or 2 (HIV-1 or HIV-2). Medium conditioned by HTLV-II-infected, transformed lines of T cells (HTLV-II CM) contained large amounts of this growth activity and also supported the temporary growth of normal vascular endothelial cells, but not fibroblasts. Interleukin-1 and tumor necrosis factor-alpha stimulated the growth of the KS-derived cells, but the growth was only transient and these could be distinguished from that in HTLV-II CM. Other known endothelial cell growth promoting factors, such as acidic and basic fibroblast growth factors and epidermal growth factor, did not support the long-term growth of the AIDS-KS cells. The factor released by CD4+ T cells infected with human retroviruses should prove useful in studies of the pathogenesis of KS.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells.
- S. Sakakibara, C. A. Pise-Masison, J. N. Brady, and G. Tosato (2009)
J. Virol.
83, 2140-2153
| Abstract »
| Full Text »
| PDF »
- Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
- Y. Xu and D. Ganem (2007)
J. Gen. Virol.
88, 46-50
| Abstract »
| Full Text »
| PDF »
- Activation of NF-{kappa}B by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype.
- C. Grossmann, S. Podgrabinska, M. Skobe, and D. Ganem (2006)
J. Virol.
80, 7179-7185
| Abstract »
| Full Text »
| PDF »
- Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis.
- L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac (2003)
Microbiol. Mol. Biol. Rev.
67, 175-212
| Abstract »
| Full Text »
| PDF »
- Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.
- G. Barillari and B. Ensoli (2002)
Clin. Microbiol. Rev.
15, 310-326
| Abstract »
| Full Text »
| PDF »
- Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor.
- R. Masood, E. Cesarman, D. L. Smith, P. S. Gill, and O. Flore (2002)
Am. J. Pathol.
160, 23-29
| Abstract »
| Full Text »
| PDF »
- Interleukin 8 Is an Autocrine Growth Factor and a Surrogate Marker for Kaposi's Sarcoma.
- R. Masood, J. Cai, A. Tulpule, T. Zheng, A. Hamilton, S. Sharma, B. M. Espina, D. L. Smith, and P. S. Gill (2001)
Clin. Cancer Res.
7, 2693-2702
| Abstract »
| Full Text »
| PDF »
- Mechanism of Paclitaxel Activity in Kaposi's Sarcoma.
- C. Sgadari, E. Toschi, C. Palladino, G. Barillari, D. Carlei, A. Cereseto, C. Ciccolella, R. Yarchoan, P. Monini, M. Sturzl, et al. (2000)
J. Immunol.
165, 509-517
| Abstract »
| Full Text »
| PDF »
- Induction of HHV-8 Lytic Cycle Replication by Inflammatory Cytokines Produced by HIV-1-Infected T Cells.
- M. Mercader, B. Taddeo, J. R. Panella, B. Chandran, B. J. Nickoloff, and K. E. Foreman (2000)
Am. J. Pathol.
156, 1961-1971
| Abstract »
| Full Text »
| PDF »
- The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi’s Sarcoma.
- D. M. Aboulafia (2000)
Chest
117, 1128-1145
| Abstract »
| Full Text »
| PDF »
- Variant genotypes of Fcgamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men.
- T. L. nbecher, C. B. Foster, S. Zhu, D. Venzon, S. M. Steinberg, K. Wyvill, J. A. Metcalf, S. S. Cohen, J. Kovacs, R. Yarchoan, et al. (2000)
Blood
95, 2386-2390
| Abstract »
| Full Text »
| PDF »
- Perspective on Kaposi's Sarcoma: Facts, Concepts, and Conjectures.
- M. S. Reitz Jr., L. S. Nerurkar, and R. C. Gallo (1999)
J Natl Cancer Inst
91, 1453-1458
| Full Text »
| PDF »
- Interleukin 17, a T-cell-derived Cytokine, Promotes Tumorigenicity of Human Cervical Tumors in Nude Mice.
- E. Tartour, F. Fossiez, I. Joyeux, A. Galinha, A. Gey, E. Claret, X. Sastre-Garau, J. Couturier, V. Mosseri, V. Vives, et al. (1999)
Cancer Res.
59, 3698-3704
| Abstract »
| Full Text »
| PDF »
- Sensitization of AIDS-Kaposi's Sarcoma Cells to Apo-2 Ligand-Induced Apoptosis by Actinomycin D.
- S. Mori, K. Murakami-Mori, S. Nakamura, A. Ashkenazi, and B. Bonavida (1999)
J. Immunol.
162, 5616-5623
| Abstract »
| Full Text »
| PDF »
- Implication of TNF Receptor-I-Mediated Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2) Activation in Growth of AIDS-Associated Kaposi's Sarcoma Cells: A Possible Role of a Novel Death Domain Protein MADD in TNF-{alpha}-Induced ERK1/2 Activation in Kaposi's Sarcoma Cells.
- K. Murakami-Mori, S. Mori, B. Bonavida, and S. Nakamura (1999)
J. Immunol.
162, 3672-3679
| Abstract »
| Full Text »
| PDF »
- Kinetics of Kaposi's Sarcoma-Associated Herpesvirus Gene Expression.
- R. Sun, S.-F. Lin, K. Staskus, L. Gradoville, E. Grogan, A. Haase, and G. Miller (1999)
J. Virol.
73, 2232-2242
| Abstract »
| Full Text »
- Endogenous Basic Fibroblast Growth Factor Is Essential for Cyclin E-CDK2 Activity in Multiple External Cytokine-Induced Proliferation of AIDS-Associated Kaposi's Sarcoma Cells: Dual Control of AIDS-Associated Kaposi's Sarcoma Cell Growth and Cyclin E-CDK2 Activity by Endogenous and External Signals.
- K. Murakami-Mori, S. Mori, and S. Nakamura (1998)
J. Immunol.
161, 1694-1704
| Abstract »
| Full Text »
| PDF »
- Glucocorticoids Induce Kaposi's Sarcoma Cell Proliferation Through the Regulation of Transforming Growth Factor-beta.
- J. Cai, T. Zheng, M. Lotz, Y. Zhang, R. Masood, and P. Gill (1997)
Blood
89, 1491-1500
| Abstract »
| Full Text »
| PDF »
- Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
- R. Masood, J. Cai, T. Zheng, D. L. Smith, Y. Naidu, and P. S. Gill (1997)
PNAS
94, 979-984
| Abstract »
| Full Text »
| PDF »
- The Effects of Preparations of Human Chorionic Gonadotropin on AIDS-Related Kaposi's Sarcoma.
- P. S. Gill, Y. Lunardi-Iskandar, S. Louie, A. Tulpule, T. Zheng, B. M. Espina, J. M. Besnier, P. Hermans, A. M. Levine, J. L. Bryant, et al. (1996)
N. Engl. J. Med.
335, 1261-1267
| Abstract »
| Full Text »
| PDF »
- Primary Pulmonary Hypertension and the Human Immunodeficiency Virus: Report of Two Cases and a Review of the Literature.
- J. R. Weiss, G. G. Pietra, and S. M. Scharf (1995)
Arch Intern Med
155, 2350-2354
| Abstract »
| PDF »
- Risk Factors for Kaposi's Sarcoma in Patients With Advanced Human Immunodeficiency Virus Disease Treated With Zidovudine.
- J. E. Gallant, R. D. Moore, D. D. Richman, J. Keruly, and R. E. Chaisson (1994)
Arch Intern Med
154, 566-572
| Abstract »
| PDF »
- HIV-Related Tumors of the Oral Cavity.
- G. Ficarra and L.E. Eversole (1994)
Critical Reviews in Oral Biology & Medicine
5, 159-185
| Abstract »
| Full Text »
| PDF »
- Kaposi's Sarcoma: Where Do We Go From Here?.
- P. L. Myskowski (1993)
Arch Dermatol
129, 1320-1323
| Abstract »
| PDF »
- Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.
- B. Nair, A. DeVico, S Nakamura, T. Copeland, Y Chen, A Patel, T O'Neil, S Oroszlan, R. Gallo, and M. Sarngadharan (1992)
Science
255, 1430-1432
| Abstract »
| PDF »
- Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
- S. Miles, O Martinez-Maza, A Rezai, L Magpantay, T Kishimoto, S Nakamura, S. Radka, and P. Linsley (1992)
Science
255, 1432-1434
| Abstract »
| PDF »
- Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex.
- S Nakamura, S Sakurada, S. Salahuddin, Y Osada, N. Tanaka, N Sakamoto, M Sekiguchi, and R. Gallo (1992)
Science
255, 1437-1440
| Abstract »
| PDF »
- Tumors of Smooth-Muscle Origin in HIV-Infected Children.
- E. G. Chadwick, E. J. Connor, I. C. G. Hanson, V. V. Joshi, H. Abu-Farsakh, R. Yogev, G. McSherry, K. McClain, and S. B. Murphy (1990)
JAMA
263, 3182-3184
| Abstract »
| PDF »
- Cutaneous Acquired Immunodeficiency Syndrome-Associated Kaposi's Sarcoma in Pediatric Patients.
- E. Connor, L. Boccon-Gibod, V. Joshi, J. Just, A. Grimfeld, S. Morrison, G. McSherry, and J. Oleske (1990)
Arch Dermatol
126, 791-793
| Abstract »
| PDF »
- Clinical Effect of Glucocorticoids on Kaposi Sarcoma Related to the Acquired Immunodeficiency Syndrome (AIDS).
- P. S. Gill, C. Loureiro, M. Bernstein-Singer, M. U. Rarick, F. Sattler, and A. M. Levine (1989)
Ann Intern Med
110, 937-940
| Abstract »
| PDF »
- Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas.
- B. Nickoloff and C. Griffiths (1989)
Science
243, 1736-1737
| PDF »
- Interferon Therapy for Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS).
- J. E. Groopman and D. T. Scadden (1989)
Ann Intern Med
110, 335-337
| Abstract »
| PDF »
- AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.
- B Ensoli, S Nakamura, S. Salahuddin, P Biberfeld, L Larsson, B Beaver, F Wong-Staal, and R. Gallo (1989)
Science
243, 223-226
| Abstract »
| PDF »
|
|